Euroapi (FRA:940) Short Interest


FRA:940 Euroapi SA FRA:940
61 GF Score
Price €1.31
GF Value €2.91
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Euroapi Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:940 vs ZTS, UTHR, VTRS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Euroapi's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Euroapi Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Euroapi's Short Interest distribution charts can be found below:

* The bar in red indicates where Euroapi's Short Interest falls into.


FRA:940
61GF Score
Euroapi SA FRA:940
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Euroapi (FRA:940) Overvalued in 2026?

Based on GuruFocus' analysis, Euroapi stock appears to be undervalued. The current stock price of €1.31 is trading 55% below its estimated GF Value™ of €2.91. GuruFocus considers Euroapi to be Possible Value Trap.

Key valuation signals for FRA:940:

  • Short Interest:
  • GF Value™: €2.91 vs. price of €1.31 (55% below fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the FRA:940 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Euroapi Business Description

Address 32 rue Alexandre Duma, Paris, FRA, 75011
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates, analgesics, and others. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers.
61GF Score

Get the complete analysis for FRA:940

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.31
Price
€2.91
GF Value